Literature DB >> 21294994

Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA).

Femke Lamers1, Patricia van Oppen, Hannie C Comijs, Johannes H Smit, Philip Spinhoven, Anton J L M van Balkom, Willem A Nolen, Frans G Zitman, Aartjan T F Beekman, Brenda W J H Penninx.   

Abstract

BACKGROUND: Comorbidity of depressive and anxiety disorders is common and has been shown to be a consistent predictor of chronicity. Comorbidity patterns among specific depressive and anxiety disorders have not been extensively reported. This study examines comorbidity patterns and temporal sequencing of separate depressive and anxiety disorders using data from a large psychiatric cohort.
METHOD: Baseline data (N = 1,783) of the Netherlands Study of Depression and Anxiety, collected between September 2004 and February 2007, were used. Current and lifetime comorbidity rates for depressive and anxiety disorders (DSM-IV-TR criteria) were calculated. Associations of comorbidity with sociodemographic, vulnerability, and clinical characteristics, and temporal sequencing of disorders were examined.
RESULTS: Of those with a depressive disorder, 67% had a current and 75% had a lifetime comorbid anxiety disorder. Of persons with a current anxiety disorder, 63% had a current and 81% had a lifetime depressive disorder. Comorbidity of depressive and anxiety disorders was associated with more childhood trauma (OR = 1.19; 95% CI, 1.06-1.33), higher neuroticism (OR = 1.05; 95% CI, 1.02-1.08), earlier age at onset of first disorder (OR = 1.59; 95% CI, 1.22-2.07), longer duration of depressive and/or anxiety symptoms (OR = 1.01; 95% CI, 1.01-1.01), and higher symptom severity (ORs ranging from 1.01 to 1.03; all P values < .05). In 57% of comorbid cases, anxiety preceded depression, and in 18%, depression preceded anxiety. Comorbidity with preceding depression compared to preceding anxiety was associated with a shorter duration of symptoms of depressive and/or anxiety symptoms (OR = 0.99; 95% CI, 0.98-0.99), earlier age at first onset (OR = 0.46; 95% CI, 0.31-0.68), and fewer fear symptoms (OR = 0.98; 95% CI, 0.97-0.99).
CONCLUSIONS: Comorbidity rates in anxiety and depressive disorders were very high, indicating that it is advisable to assess both disorders routinely regardless of the primary reason for consultation. This is especially important since comorbid patients showed a specific vulnerability pattern, with more childhood trauma, neuroticism, and higher severity and duration of symptoms. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21294994     DOI: 10.4088/JCP.10m06176blu

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  183 in total

1.  Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys.

Authors:  R C Kessler; N A Sampson; P Berglund; M J Gruber; A Al-Hamzawi; L Andrade; B Bunting; K Demyttenaere; S Florescu; G de Girolamo; O Gureje; Y He; C Hu; Y Huang; E Karam; V Kovess-Masfety; S Lee; D Levinson; M E Medina Mora; J Moskalewicz; Y Nakamura; F Navarro-Mateu; M A Oakley Browne; M Piazza; J Posada-Villa; T Slade; M Ten Have; Y Torres; G Vilagut; M Xavier; Z Zarkov; V Shahly; M A Wilcox
Journal:  Epidemiol Psychiatr Sci       Date:  2015-02-27       Impact factor: 6.892

Review 2.  The impact of sex as a biological variable in the search for novel antidepressants.

Authors:  Alexia V Williams; Brian C Trainor
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

Review 3.  Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging.

Authors:  Daniel Lindqvist; Elissa S Epel; Synthia H Mellon; Brenda W Penninx; Dóra Révész; Josine E Verhoeven; Victor I Reus; Jue Lin; Laura Mahan; Christina M Hough; Rebecca Rosser; F Saverio Bersani; Elizabeth H Blackburn; Owen M Wolkowitz
Journal:  Neurosci Biobehav Rev       Date:  2015-05-18       Impact factor: 8.989

4.  Establishment of an animal model of depression contagion.

Authors:  Matthew Boyko; Ruslan Kutz; Julia Grinshpun; Vladislav Zvenigorodsky; Shaun E Gruenbaum; Benjamin F Gruenbaum; Evgeni Brotfain; Yoram Shapira; Alexander Zlotnik
Journal:  Behav Brain Res       Date:  2014-12-15       Impact factor: 3.332

5.  Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression.

Authors:  Clarissa D Staton; Jazmine D W Yaeger; Delan Khalid; Fadi Haroun; Belissa S Fernandez; Jessica S Fernandez; Bali K Summers; Tangi R Summers; Monica Sathyanesan; Samuel S Newton; Cliff H Summers
Journal:  Neuropharmacology       Date:  2018-09-18       Impact factor: 5.250

6.  Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records.

Authors:  Anne Campbell; Steffani R Bailey; Kim A Hoffman; Javier Ponce-Terashima; Katie Fankhauser; Miguel Marino; Dennis McCarty
Journal:  J Psychoactive Drugs       Date:  2020-04-15

7.  Differential engagement of cognitive control regions and subgenual cingulate based upon presence or absence of comorbid anxiety with depression.

Authors:  Lisanne M Jenkins; Jonathan P Stange; Katie L Bessette; Yi-Shin Chang; Samantha D Corwin; Kristy A Skerrett; Víctor G Patrón; Jon-Kar Zubieta; Natania A Crane; Alessandra M Passarotti; Daniel S Pine; Scott A Langenecker
Journal:  J Affect Disord       Date:  2018-08-01       Impact factor: 4.839

8.  Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.

Authors:  Aldemara I Silva; Victor A D Holanda; Joaquim G Azevedo Neto; Edilson D Silva Junior; Vanessa P Soares-Rachetti; Girolamo Calo; Chiara Ruzza; Elaine C Gavioli
Journal:  Psychopharmacology (Berl)       Date:  2020-02-24       Impact factor: 4.530

Review 9.  Anxiety disorders and all-cause mortality: systematic review and meta-analysis.

Authors:  Beyon Miloyan; Adam Bulley; Karen Bandeen-Roche; William W Eaton; Daniela C Gonçalves-Bradley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-09-14       Impact factor: 4.328

10.  A New Method for Inducing a Depression-Like Behavior in Rats.

Authors:  Vladimir Zeldetz; Dmitry Natanel; Matthew Boyko; Alexander Zlotnik; Honore N Shiyntum; Julia Grinshpun; Dmitry Frank; Ruslan Kuts; Evgeni Brotfain; Jochanan Peiser
Journal:  J Vis Exp       Date:  2018-02-22       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.